The latest advances from BioVentures for Global Health in Africa
Published: 5 Jun 2019
Views: 286
Jennifer Dent - BioVentures for Global Health, Seattle, USA
Jennifer Dent speaks to ecancer at the Global Health Catalyst Summit 2019 at the Dana Farber Cancer Institute in Boston, Massachusetts about the progress of BioVentures for Global Health since her last interview at AACR in April.
She outlines three of the current projects from BioVentures, including improving access in Nigeria, capacity building in Côte d'Ivoire, and launching new work in Senegal.
Jennifer also describes some of the main reasons we need to build capacity and access in these areas, and how momentum is building in this promising field.
Related Videos
Cancer care in low and middle income countries
Dr Gouri Bhattacharyya - FORTIS Hospital, Kolkata, India
12 Jul 2019
Challenges in global cancer control
Prof Mary Gospodarowicz
12 Jul 2019
How will ASCO combat cancer disparities?
Dr Richard Schilsky and Dr Eduardo Cazap
12 Jul 2019
Prof Ahmed Elzawawy on global cancer control
Prof Ahmed Elzawawy, Dr Eduardo Cazap
12 Jul 2019
The global program of the American Cancer Society
Dr Meg O'Brien - American Cancer Society, Atlanta, USA
5 Jun 2019
Running a cancer hospital in rural Cameroon
Dennis Palmer - CIMP Program Director, Mbingo Baptist Hospital, Cameroon
5 Jun 2019
The 10th Anniversary of the WIN Consortium: lessons and perspectives
Dr Richard Schilsky - American Society Of Clinical Oncology, USA
9 Jul 2018
Inequalities in immuno-oncology access across Europe
Dr Lydia Makaroff - European Cancer Patient Coalition, Brussels, Belgium
14 Dec 2017
Lifestyle diseases accountable for soaring healthcare costs
Peter Hongaard Anderson - Innovation Fund, Copenhagen, Denmark
6 Dec 2017
